The Efficacy of Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration
Author:
Affiliation:
1. Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Publisher
Korean Ophthalmological Society
Subject
Ophthalmology
Link
https://synapse.koreamed.org/pdf/10.3341/jkos.2009.50.5.725
Reference21 articles.
1. Prevalence of Age-related Maculopathy
2. Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy
3. THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASE
4. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration
5. Ranibizumab for Predominantly Classic Neovascular Age-related Macular Degeneration: Subgroup Analysis of First-year ANCHOR Results
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hemodynamic Change after Intravitreal Anti-vascular Endothelial Growth Factor Injection;Journal of Retina;2020-05-31
2. Clinical Course of Patients with Neovascular Age-related Macular Degeneration Who Experienced Visual Deterioration after Treatment despite Initially Good Visual Acuity;Journal of Retina;2019-05-31
3. Influence of Axial Length on Recurrence of Wet Age-related Macular Degeneration after Initial Treatment;Journal of the Korean Ophthalmological Society;2019
4. Efficacy of Three Aflibercept Injections for Neovascular Age-related Macular Degeneration Showing Limited Response to Ranibizumab;Journal of the Korean Ophthalmological Society;2017
5. Fourteen Anti-vascular Endothelial Growth Factor Injections for Age-related Macular Degeneration: Ending Period and Clinical Outcome;Journal of the Korean Ophthalmological Society;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3